CEN BIOTECH INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cen Biotech Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2022.
  • Cen Biotech Inc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2022 was $95.4K, a 36.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $95.4K -$54.9K -36.5% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $112K Jun 30, 2022 10-Q 2022-08-22
Q1 2022 $125K Mar 31, 2022 10-Q 2022-05-20
Q4 2021 $138K +$138K Dec 31, 2021 10-Q 2022-11-14
Q3 2021 $150K Sep 30, 2021 10-Q 2021-11-19
Q4 2020 $0 -$229K -100% Dec 31, 2020 10-K 2022-04-14
Q2 2020 $196K -$54.8K -21.9% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $199K -$52.1K -20.7% Mar 31, 2020 10-Q 2020-06-12
Q4 2019 $229K Dec 31, 2019 10-K 2021-03-12
Q3 2019 $236K Sep 30, 2019 10-Q 2019-11-18
Q2 2019 $250K Jun 30, 2019 10-Q 2019-08-19
Q1 2019 $251K Mar 31, 2019 10-Q 2019-05-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.